Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
Acorda markets two FDA-approved therapies, including INBRIJATM (levodopa inhalation powder) 42 mg capsules.